0001104659-23-032338.txt : 20230314 0001104659-23-032338.hdr.sgml : 20230314 20230314170047 ACCESSION NUMBER: 0001104659-23-032338 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230312 FILED AS OF DATE: 20230314 DATE AS OF CHANGE: 20230314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Power Sean A CENTRAL INDEX KEY: 0001538845 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 23731840 MAIL ADDRESS: STREET 1: 787 SEVENTH AVENUE, 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TG THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (212) 554-4484 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030310 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 tm239588-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2023-03-12 0 0001001316 TG THERAPEUTICS, INC. TGTX 0001538845 Power Sean A 3020 CARRINGTON MILL BLVD, SUITE 475 MORRISVILLE NC 27560 0 1 0 0 Chief Financial Officer COMMON STOCK 2023-03-12 4 A 0 85000 0 A 728483 D Reflects a grant of restricted shares, of which 1/4 will vest on 1/1/2024, 1/4 will vest on 1/1/2025, 1/4 will vest on 1/1/2026, and 1/4 will vest on 1/1/2027. Includes shares of restricted Common Stock, which vest over various time periods. /s/ Sean A. Power 2023-03-14